Four Dana-Farber Researchers Awarded Prestigious “Outstanding Investigator Awards” by National Cancer Institute

The National Cancer Institute (NCI) has awarded four Dana-Farber Cancer Institute researchers with Outstanding Investigator Awards (OIA) for ongoing progressive research within their respective areas of study.
2-Jun-2017 10:05 AM EDT Add to Favorites

Dana-Farber Cancer Institute Names Lesley Solomon SVP, Chief Innovation Officer

Dana-Farber Cancer Institute has named Lesley Solomon to the newly-created position of senior vice president for innovation and chief innovation officer. Solomon has been serving as executive director of the Brigham Innovation Hub at Brigham and...
31-May-2017 11:05 AM EDT Add to Favorites

Backed by Dana-Farber Research, FDA Approves New AML Drug

A targeted drug whose clinical testing was led by Richard Stone, MD, of Dana-Farber Cancer Institute, has become the first new treatment for newly diagnosed acute myeloid leukemia (AML) in more than 25 years.
5-May-2017 12:05 PM EDT Add to Favorites

Dana-Farber/Harvard Cancer Center Leader Wins 'Reducing Health Disparities Award' From Mass Medical Society

Karen Burns White, Deputy Associate Director of Dana-Farber/Harvard Cancer Center’s (DF/HCC) Initiative to Eliminate Cancer Disparities (IECD) since 2001, has been honored by the Massachusetts Medical Society as the 2017 recipient of the...
18-Apr-2017 3:05 PM EDT Add to Favorites

Dana-Farber Cancer Institute Named Top 100 Great Hospital in America

Dana-Farber Cancer Institute has been recognized as a “Top 100 Great Hospital in America” by Becker's Hospital Review.
18-Apr-2017 3:05 PM EDT Add to Favorites

Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School to Convene 2017 Global Health Catalyst Cancer Summit

The Global Health Catalyst Cancer Summit is an annual event that provides a forum for global health stakeholders to network, share knowledge and strengthen high-impact international collaborations that save lives while reducing global health...
18-Apr-2017 3:05 PM EDT Add to Favorites

Dana-Farber Recognized as National Leader in LGBTQ-Inclusiveness

For the fifth time in five years, Dana-Farber Cancer Institute has been recognized as a leader in LGBTQ Healthcare Equity by the Human Rights Campaign (HRC) Foundation. The distinction is achieved through evaluation by the Healthcare Equality Index...
18-Apr-2017 3:05 PM EDT Add to Favorites

Drug Combination Shows Benefit in RAS-Driven Cancers

Dana-Farber Cancer Institute scientists report a number of patients in a small study with RAS-driven lung, ovarian, and thyroid cancers got long-term clinical benefit from a combination of two drugs that targeted molecular pathways controlled by the...
3-Apr-2017 4:05 PM EDT Add to Favorites